Similar to what has been observed for HERC1, we did not detect any significant difference in terms of HERC2 gene expression between the PB and BM samples from CML samples obtained at diagnosis. This evidence concerns the gene HERC2 and chronic myelogenous leukemia, BCR-ABL1 positive.